[Photo] Researchers Sweating It Out in COVID-19 Treatment Research
Countries around the world are racing to develop vaccines and treatments to overcome the novel coronavirus disease (COVID-19). Korean bio venture company Engicam Life Sciences has received approval for a new drug substance from the U.S. Food and Drug Administration (FDA) and is conducting Phase 2 clinical trials. Ahead of the New Year 2021, a researcher is fully engaged in COVID-19 treatment research at Engicam Life Sciences' central research institute in Jecheon, Chungbuk./Jecheon=Reporter Kang Jinhyung aymsdream@
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 40s Who Kept Girlfriend's Body for a Year After Murder Sentenced to 30 Years in Prison Again on Appeal
- "Striking Will Lead to Regret": Hyundai-Kia Employees Speak Out... Uneasy Stares Toward Samsung Union
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.